Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years

Nicole Toepfner, Wolfgang C G von Meißner, Christoph Strumann, Denisa Drinka, David Stuppe, Maximilian Jorczyk, Jeanne Moor, Johannes Püschel, Melanie Liss, Emilie von Poblotzki, Reinhard Berner, Matthias B Moor, Cho-Ming Chao

Fingerprint

Untersuchen Sie die Forschungsthemen von „Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science